NL-OMON51551
Recruiting
N/A
Early prediction of treatment response in children with Inflammatory Bowel Disease with Intestinal Ultrasound - RAINBOW-3
Overview
- Phase
- N/A
- Intervention
- Not specified
- Conditions
- Not specified
- Sponsor
- Academisch Medisch Centrum
- Enrollment
- 120
- Status
- Recruiting
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Newly onset IBD or flare IBD
- •Starting new remission induction therapy
Exclusion Criteria
- •No visible abnormalities on baseline IUS
- •Infectious gastroenteritis
- •Acute severe ulcerative colitis
- •Surgery as remission induction therapy
- •Previous intestinal surgery
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
N/A
Prediction of medication response in children with ADHD: EEG differences between responders and non-responders to methylphenidate.ADHD, methylphenidate response, EEG, DNA, CANTAB, spatial span, spatial working memory, stop-task, CPT, theta/beta ratioNL-OMON26488trecht Institute for Pharmaceutical Sciences, Utrecht University50
Completed
N/A
Prediction of medication response in children with Attention Deficit Hyperactivity Disorder (ADHD): Electroencephalogram (EEG) differences between responders and non-responders to methylphenidateMedication response in children with Attention Deficit Hyperactivity Disorder (ADHD)Mental and Behavioural DisordersHyperkinetic disordersISRCTN32841168trecht Institute for Pharmaceutical Sciences (The Netherlands)50
Completed
N/A
Assessing effectiveness and safety of two medications :nasal ketamine and oral promethazine as premedication in pediatric patients undergoing routine operationsHealth Condition 1: null- 60 patients of ASA I of age group 2-8 years scheduled for elective general surgeries, urosurgeries, plastic surgeries and ENT were randomly selected and taken in to study.CTRI/2016/03/006704St Stephens Hospital Delhi
Recruiting
N/A
Prediction of therapy response and treatment outcomes in early course of schizophrenia.Subproject D1_AP2 of the research network ESPRIT (Enhancing Schizophrenia Prevention and Recovery through Innovative Treatments)DSM IV-TR:295.10-30, 295.90: Schizophrenia High Risc State of transmission to psychosisDRKS00010936Klinik und Poliklinik für Psychiatrie und Psychotherapie,LVR-Klinikum Düsseldorf / Kliniken der Heinrich Heine Universität Düsseldorf600
Active, Not Recruiting
Phase 1
Traitement précoce de patients pédiatriques présentant un syndrome hémolytique et urémique typique par l’anticorps monoclonal anti-C5 eculizumab : essai thérapeutique prospectif randomisé contrôlé contre placebo de phase IIIHemolytic and uremic syndromeMedDRA version: 17.0 Level: LLT Classification code 10042814 Term: Syndrome hemolytic uremic System Organ Class: 100000004851Therapeutic area: Diseases [C] - Symptoms and general pathology [C23]EUCTR2014-001169-28-FRCentre Hospitalier de Toulouse100